Clinical trial
Safety and Effectiveness of SOFIA™/SOFIA™ PLUS When Used for Direct Aspiration as a First Line Treatment Technique in Patients Suffering an Acute Ischemic Stroke in the Anterior Circulation
NCT03417349 is registered in ClinicalTrials.gov with Dr. Markus Alfred Möhlenbruch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of SOFIA™/SOFIA™ PLUS When Used for Direct Aspiration as a First Line Treatment Technique in Patients Suffering an Acute Ischemic Stroke in the Anterior Circulation
- Lead sponsor
- Dr. Markus Alfred Möhlenbruch
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2017
- Completion date
- March 15, 2022
- Enrollment
- 250 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral stroke, cerebrovascular stroke, stroke, acute